Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Dr. Reddy's Laboratories Limited

RDY•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.35
$0.00(0.00%)
U.S. Market is Open • 12:58

Dr. Reddy's Laboratories Limited (RDY) Stock Overview

Explore Dr. Reddy's Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.1B
P/E Ratio19.36
EPS (TTM)$0.75
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$13.05
3 Months$12.53
1 Year Target$13.14

RDY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dr. Reddy's Laboratories Limited (RDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.36 and a market capitalization of 12.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.91%
5-Day Change
1.61%
1-Month Change
11.90%
3-Month Change
4.17%
6-Month Change
2.48%
Year-to-Date (YTD) Change
4.47%
1-Year Change
7.74%
3-Year Change
32.84%
5-Year Change
18.49%
All-Time (Max) Change
1333.66%

Contact Information

https://www.drreddys.com
91 40 4900 2900
8-2-337, Road No. 3, Hyderabad, NaN, 500034

Company Facts

270,480 Employees
IPO DateApr 11, 2001
CountryIN
Actively Trading

Frequently Asked Questions